
Is China the next global biopharma powerhouse?
Regulatory reform and investment in innovation have supercharged China’s biopharma sector, but will ongoing trade wars with the US pose a risk to growth? By Diana Turner. China’s role in the global biopharma sector has grown significantly in recent years. It is the world's largest supplier of active pharmaceutical ingredients (APIs) and in… Read More















